[HTML][HTML] Uses of misoprostol in obstetrics and gynecology

R Allen, BM O'Brien - Reviews in obstetrics and gynecology, 2009 - ncbi.nlm.nih.gov
Misoprostol is a synthetic prostaglandin E 1 analogue that is used off-label for a variety of
indications in the practice of obstetrics and gynecology, including medication abortion …

Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services

RJ Gomperts, K Jelinska, S Davies… - … Journal of Obstetrics …, 2008 - Wiley Online Library
Women on Web is a service that uses telemedicine to help women access mifepristone and
misoprostol in countries with no safe care for termination of pregnancy (TOP). This study …

[HTML][HTML] Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety

P Bouchard, N Chabbert-Buffet, BCJM Fauser - Fertility and sterility, 2011 - Elsevier
OBJECTIVE: To discuss the mechanism of action of selective progesterone receptor
modulators (SPRMs) and summarize the preclinical and clinical efficacy and safety data …

Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial

KS Oppegaard, E Qvigstad, C Fiala, O Heikinheimo… - The Lancet, 2015 - thelancet.com
Background Medical abortion with mifepristone and prostaglandins is well established. We
compared clinical assessment with self-assessment of abortion outcome. Methods This …

Early versus delayed insertion of intrauterine contraception after medical abortion—a randomized controlled trial

I Sääv, O Stephansson, K Gemzell-Danielsson - PloS one, 2012 - journals.plos.org
Background Today, a large proportion of early abortions are medical terminations, in
accordance to the woman's choice. Intrauterine contraceptives (IUC) provide highly effective …

Management of early pregnancy loss, with a focus on patient centered care

JM Shorter, JM Atrio, CA Schreiber - Seminars in perinatology, 2019 - Elsevier
Early pregnancy loss is the most common complication in pregnancy. Management options
for miscarriage include expectant management, medical intervention, or surgical aspiration …

Mifepristone in second-trimester medical abortion: a randomized controlled trial

N Kapp, L Borgatta, P Stubblefield… - Obstetrics & …, 2007 - journals.lww.com
OBJECTIVE: To investigate the adjunctive use of mifepristone in second-trimester induction
abortions using misoprostol 1 day after feticidal digoxin. METHODS: This is a randomized …

Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review

E Jackson, N Kapp - Contraception, 2011 - Elsevier
BACKGROUND: Pain is a predictable feature of medical abortion in both the first trimester
and the second trimester. We sought to evaluate optimal analgesia regimens during medical …

Mifepristone: where do we come from and where are we going?: Clinical development over a quarter of a century

IM Spitz - Contraception, 2010 - Elsevier
Administration of mifepristone followed by the prostaglandin, misoprostol, has been used
successfully in the medical termination of pregnancy for over 25 years, and the method is …

Efficient and versatile catalytic systems for the n-methylation of primary amines with methanol catalyzed by N-heterocyclic carbene complexes of iridium

G Toyooka, A Tuji, K Fujita - Synthesis, 2018 - thieme-connect.com
Efficient and versatile catalytic systems were developed for the N-methylation of both
aliphatic and aromatic primary amines using methanol as the methylating agent. Iridium …